Paul Rivard's Insider Trades & SAST Disclosures

Paul Rivard's most recent trade in TNF Pharmaceuticals Inc. was a trade of 150,000 Common stock done at an average price of $1.1 . Disclosure was reported to the exchange on Aug. 24, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
TNF Pharmaceuticals Inc.
Paul Rivard Chief Legal Officer Purchase of securities on an exchange or from another person at price $ 1.11 per share. 24 Aug 2023 150,000 400,000 - 1.1 166,500 Common stock
TNF Pharmaceuticals Inc.
Paul Rivard Chief Legal Officer Purchase of securities on an exchange or from another person at price $ 1.12 per share. 17 Aug 2023 25,000 250,000 - 1.1 28,080 Common stock
TNF Pharmaceuticals Inc.
Paul Rivard Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 150,000 150,000 - - Employee Stock Option (Right to Buy)
TNF Pharmaceuticals Inc.
Paul Rivard EVP of Operations, GC Purchase of securities on an exchange or from another person at price $ 1.53 per share. 08 Dec 2022 10,000 225,000 - 1.5 15,300 Common stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades